Abcuro (Series C)
Funding Details
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $200,000,000
Company Info
- Founding Year
- 2012
- Company Description
- Abcuro is developing therapies for autoimmune diseases and certain cancers by targeting specific immune cells.
- Market
- Healthcare
- Location
- Newton, Massachusetts, USA
- Coinvestors
- NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax, Mass General Brigham Ventures, New Leaf Ventures, abrdn, BlackRock, Eurofarma Ventures, Soleus Capital